From the commercialisation of cell and gene therapies, to the production of monoclonal antibodies (mAbs), vaccines and antibody drug conjugate medicines, modern biotechnology is discovering, developing and manufacturing products to fight the most acute and challenging diseases.
At BakerHicks, we’re working with the world’s leading biotech companies and are proud to be joining the fight against the COVID-19 pandemic, cancer, neurodegenerative and cardiovascular disease, immune system suppression, diabetes, viral infections and beyond. We’re able to plan a facility from the inside out, with experience in delivering to ultra-fast schedules and within live production environments.
In a rapidly growing, global market, it’s important to our clients that they can respond with agility and speed. From feasibility, through full project delivery, qualification and handover of cGMP facilities, we transform ideas into sustainable, commercially viable processes. Using our technical skills across all platforms including upstream and downstream processing, single use technology, clean and black utilities, laboratory and facility design, our teams are respected for their delivery of lean, cost-effective, compliant and futureproofed solutions.